KEGG   DRUG: Glepaglutide
Entry
D11337                      Drug                                   
Name
Glepaglutide (USAN);
Zeydovio (TN)
Formula
C197H325N53O55
Exact mass
4313.4264
Mol weight
4316.01
Structure
Sequence
HGEGTFSSEL ATILDALAAR DFIAWLIATK ITDKKKKKK
  Type
Peptide
Remark
ATC code: A16AX26
Efficacy
Anti-inflammatory, Glucagon-like peptide 2 receptor agonist
Comment
Treatment of short bowel syndrome
Target
GLP2R [HSA:9340] [KO:K04582]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AX Various alimentary tract and metabolism products
     A16AX26 Glepaglutide
      D11337  Glepaglutide (USAN)
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Glucagon
    GLP2R
     D11337  Glepaglutide (USAN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11337
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11337
Other DBs
PubChem: 384585315
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system